FASEB
@faseborg.bsky.social
Advancing health and well-being in the life sciences through collaborative advocacy. We are the voice of biological/biomedical researchers.🔬
www.faseb.org
https://linktr.ee/FASEBorg
www.faseb.org
https://linktr.ee/FASEBorg
💡 In case you didn't know: FASEB’s Assessing Scientific Need for Animal Models (ASNAM) Initiative supports expert-driven perspectives that inform science policy with evidence. #FASEB #AnimalResearch
February 11, 2026 at 8:00 PM
💡 In case you didn't know: FASEB’s Assessing Scientific Need for Animal Models (ASNAM) Initiative supports expert-driven perspectives that inform science policy with evidence. #FASEB #AnimalResearch
📢 Now published: the first article from FASEB’s ASNAM Initiative! Authored by leading musculoskeletal researchers, it outlines why animal models remain essential to advancing musculoskeletal research amid growing use of alternative methods. Read the full article: buff.ly/X72tqwX
February 11, 2026 at 8:00 PM
📢 Now published: the first article from FASEB’s ASNAM Initiative! Authored by leading musculoskeletal researchers, it outlines why animal models remain essential to advancing musculoskeletal research amid growing use of alternative methods. Read the full article: buff.ly/X72tqwX
Stay informed on what’s happening on Capitol Hill, the latest science policy developments, advocacy efforts, and news from federal science agencies. Subscribe to the Washington Update newsletter here: buff.ly/kR1f0mn
February 10, 2026 at 5:05 PM
Stay informed on what’s happening on Capitol Hill, the latest science policy developments, advocacy efforts, and news from federal science agencies. Subscribe to the Washington Update newsletter here: buff.ly/kR1f0mn
#ICYMI FASEB issues a statement strongly supporting #NPRCs amid ongoing state-level animal rights campaigns & growing federal pressure. NPRCs are essential national shared resources that operate with transparency, accountability, & the highest standards of scientific integrity. buff.ly/iDPxGUR
February 9, 2026 at 3:56 PM
#ICYMI FASEB issues a statement strongly supporting #NPRCs amid ongoing state-level animal rights campaigns & growing federal pressure. NPRCs are essential national shared resources that operate with transparency, accountability, & the highest standards of scientific integrity. buff.ly/iDPxGUR
FASEB issues a statement supporting the National Primate Research Centers amid ongoing state-level animal rights campaigns and growing federal pressure on the institutions. OHSU Board will hold a public meeting on the future of the Oregon NPRC on February 9. Read our full statement:
FASEB Issues Statement of Support for National Primate Research Centers
FASEB issues statement supporting NPRCs, highlighting their essential role in advancing safe, transparent, and high-quality biomedical research.
buff.ly
February 5, 2026 at 4:15 PM
FASEB issues a statement supporting the National Primate Research Centers amid ongoing state-level animal rights campaigns and growing federal pressure on the institutions. OHSU Board will hold a public meeting on the future of the Oregon NPRC on February 9. Read our full statement:
🧠 One strategy, multiple targets.
This open-access study from FASEB Journal shows how pairing isoquercetin with zafirlukast can reduce tumor growth, inflammation, and clot-related signaling in ovarian cancer—highlighting a new way to tackle cancer and thrombosis together.
🔗
This open-access study from FASEB Journal shows how pairing isoquercetin with zafirlukast can reduce tumor growth, inflammation, and clot-related signaling in ovarian cancer—highlighting a new way to tackle cancer and thrombosis together.
🔗
Isoquercetin and Zafirlukast Cooperatively Suppress Tumor Growth and Thromboinflammatory Signaling in a Xenograft Model of Ovarian Cancer
Cancer-associated thrombosis (CAT), encompassing both venous ...
buff.ly
February 5, 2026 at 4:03 PM
🧠 One strategy, multiple targets.
This open-access study from FASEB Journal shows how pairing isoquercetin with zafirlukast can reduce tumor growth, inflammation, and clot-related signaling in ovarian cancer—highlighting a new way to tackle cancer and thrombosis together.
🔗
This open-access study from FASEB Journal shows how pairing isoquercetin with zafirlukast can reduce tumor growth, inflammation, and clot-related signaling in ovarian cancer—highlighting a new way to tackle cancer and thrombosis together.
🔗
#ICYMI: 📝 FASEB's comments to NSF on its FY 2026–2030 Strategic Plan highlights how timely communication and active engagement with the scientific community help move the agency’s goals forward. Read our comments here:
FASEB Submits Feedback on NSF FY 2026–2030 Strategic Plan
FASEB submitted comments in response to the Dear Colleague Letter issued by the National Science Foundation.
buff.ly
February 5, 2026 at 2:03 PM
#ICYMI: 📝 FASEB's comments to NSF on its FY 2026–2030 Strategic Plan highlights how timely communication and active engagement with the scientific community help move the agency’s goals forward. Read our comments here:
🧬🧠 Inflammation doesn’t stop when a stroke ends.
This study links a specific immune signaling pathway (CCL11–CCR3) to damaging cell death in brain support cells after stroke—fueling inflammation and harming neuron connections.
🔗
This study links a specific immune signaling pathway (CCL11–CCR3) to damaging cell death in brain support cells after stroke—fueling inflammation and harming neuron connections.
🔗
The CCL11‐CCR3 Axis Regulates the Aggravation of Neuroinflammation in Astrocytic Necroptosis After Cerebral Ischemia
Schematic diagram of the triggering mechanism of necroptosis after cerebral ischemia. First, CCL11 targetedly binds to CCR3 on the surface of astrocytes and upregulates the expression of CCR3. After…
buff.ly
February 4, 2026 at 3:15 PM
🧬🧠 Inflammation doesn’t stop when a stroke ends.
This study links a specific immune signaling pathway (CCL11–CCR3) to damaging cell death in brain support cells after stroke—fueling inflammation and harming neuron connections.
🔗
This study links a specific immune signaling pathway (CCL11–CCR3) to damaging cell death in brain support cells after stroke—fueling inflammation and harming neuron connections.
🔗
🧬🦷 When force meets biology.
This FASEB Journal review breaks down how orthodontic pressure can disrupt tooth root homeostasis, triggering inflammation and cell damage that lead to root resorption—and why understanding these mechanisms is key to safer orthodontic treatments.
🔗 buff.ly/CiakNqS
This FASEB Journal review breaks down how orthodontic pressure can disrupt tooth root homeostasis, triggering inflammation and cell damage that lead to root resorption—and why understanding these mechanisms is key to safer orthodontic treatments.
🔗 buff.ly/CiakNqS
February 3, 2026 at 8:05 PM
🧬🦷 When force meets biology.
This FASEB Journal review breaks down how orthodontic pressure can disrupt tooth root homeostasis, triggering inflammation and cell damage that lead to root resorption—and why understanding these mechanisms is key to safer orthodontic treatments.
🔗 buff.ly/CiakNqS
This FASEB Journal review breaks down how orthodontic pressure can disrupt tooth root homeostasis, triggering inflammation and cell damage that lead to root resorption—and why understanding these mechanisms is key to safer orthodontic treatments.
🔗 buff.ly/CiakNqS
📢 Why do coalitions matter in advocacy? Hear from Leland Cogliani of Lewis-Burke Associates LLC at FASEB’s Advocacy Town Hall as he breaks down the power of collective action. Register for FREE: buff.ly/001itxL
February 3, 2026 at 1:01 PM
📢 Why do coalitions matter in advocacy? Hear from Leland Cogliani of Lewis-Burke Associates LLC at FASEB’s Advocacy Town Hall as he breaks down the power of collective action. Register for FREE: buff.ly/001itxL
📢 Coalitions amplify voices and strengthen outcomes. Don't miss FASEB’s upcoming Advocacy Town Hall to learn from Leland Cogliani of Lewis-Burke Associates LLC about how coalition advocacy works and why it matters. 🔗https://buff.ly/001itxL
February 2, 2026 at 5:06 PM
📢 Coalitions amplify voices and strengthen outcomes. Don't miss FASEB’s upcoming Advocacy Town Hall to learn from Leland Cogliani of Lewis-Burke Associates LLC about how coalition advocacy works and why it matters. 🔗https://buff.ly/001itxL
🧪🌿 From plants to pathways.
This review in The FASEB Journal summarizes how β-caryophyllene, a plant-derived compound, may protect the liver by calming inflammation, reducing scarring, and improving fat metabolism—while underscoring the need for clinical validation.
🔗 buff.ly/AyT3vBc
This review in The FASEB Journal summarizes how β-caryophyllene, a plant-derived compound, may protect the liver by calming inflammation, reducing scarring, and improving fat metabolism—while underscoring the need for clinical validation.
🔗 buff.ly/AyT3vBc
February 2, 2026 at 3:56 PM
🧪🌿 From plants to pathways.
This review in The FASEB Journal summarizes how β-caryophyllene, a plant-derived compound, may protect the liver by calming inflammation, reducing scarring, and improving fat metabolism—while underscoring the need for clinical validation.
🔗 buff.ly/AyT3vBc
This review in The FASEB Journal summarizes how β-caryophyllene, a plant-derived compound, may protect the liver by calming inflammation, reducing scarring, and improving fat metabolism—while underscoring the need for clinical validation.
🔗 buff.ly/AyT3vBc
📝 FASEB submits comments to NSF on its FY 2026–2030 Strategic Plan, highlighting how timely communication and active engagement with the scientific community help move the agency’s goals forward. Read the comments: buff.ly/goWQag5
January 30, 2026 at 5:03 PM
📝 FASEB submits comments to NSF on its FY 2026–2030 Strategic Plan, highlighting how timely communication and active engagement with the scientific community help move the agency’s goals forward. Read the comments: buff.ly/goWQag5
🩺🧬 Peritoneal dialysis saves lives—but long-term use can lead to tissue scarring.
This review in FASEB Journal breaks down how faulty cell-to-cell communication drives peritoneal fibrosis and highlights new strategies to slow damage and improve outcomes for kidney patients.
🔗 buff.ly/YBH477y
This review in FASEB Journal breaks down how faulty cell-to-cell communication drives peritoneal fibrosis and highlights new strategies to slow damage and improve outcomes for kidney patients.
🔗 buff.ly/YBH477y
January 30, 2026 at 3:56 PM
🩺🧬 Peritoneal dialysis saves lives—but long-term use can lead to tissue scarring.
This review in FASEB Journal breaks down how faulty cell-to-cell communication drives peritoneal fibrosis and highlights new strategies to slow damage and improve outcomes for kidney patients.
🔗 buff.ly/YBH477y
This review in FASEB Journal breaks down how faulty cell-to-cell communication drives peritoneal fibrosis and highlights new strategies to slow damage and improve outcomes for kidney patients.
🔗 buff.ly/YBH477y
NIH announces several developments at the agency, including leadership updates, a proposed reorganization within DPCPSI, and updated OLAW guidance on prompt reporting. Read more in the Washington Update: buff.ly/oXn9t7X
January 29, 2026 at 6:02 PM
NIH announces several developments at the agency, including leadership updates, a proposed reorganization within DPCPSI, and updated OLAW guidance on prompt reporting. Read more in the Washington Update: buff.ly/oXn9t7X
🧬🦠 Flu viruses don’t act alone—they rely on our cells.
This review in the FASEB Journal explains how noncoding RNAs inside human cells can either support or suppress influenza A infection, pointing toward new ways to control the virus.
🔗 buff.ly/EIwrFiR
This review in the FASEB Journal explains how noncoding RNAs inside human cells can either support or suppress influenza A infection, pointing toward new ways to control the virus.
🔗 buff.ly/EIwrFiR
January 28, 2026 at 7:43 PM
🧬🦠 Flu viruses don’t act alone—they rely on our cells.
This review in the FASEB Journal explains how noncoding RNAs inside human cells can either support or suppress influenza A infection, pointing toward new ways to control the virus.
🔗 buff.ly/EIwrFiR
This review in the FASEB Journal explains how noncoding RNAs inside human cells can either support or suppress influenza A infection, pointing toward new ways to control the virus.
🔗 buff.ly/EIwrFiR
A federal appeals court will fast-track the review of the Trump administration’s $100,000 supplemental H-1B visa fee, which could significantly affect universities and research employers relying on international talent. Read more in the Washington Update: buff.ly/YFJ5UR3
January 28, 2026 at 3:56 PM
A federal appeals court will fast-track the review of the Trump administration’s $100,000 supplemental H-1B visa fee, which could significantly affect universities and research employers relying on international talent. Read more in the Washington Update: buff.ly/YFJ5UR3
📰 The latest in the Washington Update: NIH releases a new trans-agency NOFO for the new PF5 award structure for research collaborations with international components. Effective for grant submissions on or after May 25. Read more: buff.ly/rfefVCU
January 27, 2026 at 2:02 PM
📰 The latest in the Washington Update: NIH releases a new trans-agency NOFO for the new PF5 award structure for research collaborations with international components. Effective for grant submissions on or after May 25. Read more: buff.ly/rfefVCU
NIH is seeking public input on proposed updates to its Controlled-Access Data and Genomic Data Sharing policies to strengthen protections for human participant research data. Comments due March 18. Read more in the Washington Update: buff.ly/1780AFf
January 26, 2026 at 3:56 PM
NIH is seeking public input on proposed updates to its Controlled-Access Data and Genomic Data Sharing policies to strengthen protections for human participant research data. Comments due March 18. Read more in the Washington Update: buff.ly/1780AFf
New issue of Washington Update just dropped! Stay informed on what’s happening on Capitol Hill, the latest science policy developments, advocacy efforts, and news from federal science agencies. Read the full issue here ➡️ buff.ly/ikLuEge
January 23, 2026 at 2:30 PM
New issue of Washington Update just dropped! Stay informed on what’s happening on Capitol Hill, the latest science policy developments, advocacy efforts, and news from federal science agencies. Read the full issue here ➡️ buff.ly/ikLuEge
Join us TODAY to rally advocates nationwide for research funding that saves lives and drives innovation. Congress has advanced NIH funding. Lawmakers must act swiftly to pass the bill so that lifesaving research isn’t delayed. Call or email your Member of Congress: hubs.ly/Q03_1xcG0 #UnitedForCures
Day of Action — United For Cures
Please ask your elected officials in Washington to increase federal funding for lifesaving medical research. Now is the time to make sure America’s fight for cures is funded.
hubs.ly
January 21, 2026 at 8:15 PM
Join us TODAY to rally advocates nationwide for research funding that saves lives and drives innovation. Congress has advanced NIH funding. Lawmakers must act swiftly to pass the bill so that lifesaving research isn’t delayed. Call or email your Member of Congress: hubs.ly/Q03_1xcG0 #UnitedForCures
Today is United for Cures’ Social Media Day of Action, and FASEB is proud to participate. Congress has taken an important step by advancing FY26 funding for medical research. Now, lawmakers must act swiftly to pass the bill, so lifesaving research isn’t delayed. buff.ly/itnx7NR #CuresCantWait
National Day of Action
Ask your elected officials in Washington to increase federal funding for lifesaving medical research.
hubs.ly
January 21, 2026 at 2:01 PM
Today is United for Cures’ Social Media Day of Action, and FASEB is proud to participate. Congress has taken an important step by advancing FY26 funding for medical research. Now, lawmakers must act swiftly to pass the bill, so lifesaving research isn’t delayed. buff.ly/itnx7NR #CuresCantWait
🍵 Research spotlight!
An in vitro study in The FASEB Journal on tea catechins inhibiting intestinal GLUT sugar transporters is cited in The State’s health coverage on blood sugar management.
What tea do you need to drink? Read more: buff.ly/kHnZYQ3
An in vitro study in The FASEB Journal on tea catechins inhibiting intestinal GLUT sugar transporters is cited in The State’s health coverage on blood sugar management.
What tea do you need to drink? Read more: buff.ly/kHnZYQ3
January 20, 2026 at 9:19 PM
🍵 Research spotlight!
An in vitro study in The FASEB Journal on tea catechins inhibiting intestinal GLUT sugar transporters is cited in The State’s health coverage on blood sugar management.
What tea do you need to drink? Read more: buff.ly/kHnZYQ3
An in vitro study in The FASEB Journal on tea catechins inhibiting intestinal GLUT sugar transporters is cited in The State’s health coverage on blood sugar management.
What tea do you need to drink? Read more: buff.ly/kHnZYQ3
Tomorrow is @unitedforcures.bsky.social’s National Day of Action! Join FASEB in urge Congress to increase federal funding for medical research in FY 2026. Register here:🔗 buff.ly/xbLm5Yn #SupportCures #FundMedicalResearch #CuresCantWait
January 20, 2026 at 7:02 PM
Tomorrow is @unitedforcures.bsky.social’s National Day of Action! Join FASEB in urge Congress to increase federal funding for medical research in FY 2026. Register here:🔗 buff.ly/xbLm5Yn #SupportCures #FundMedicalResearch #CuresCantWait
Happening today at noon ET! FASEB's Ellen Kuo will share what advocacy strategies are effective, what’s changed, and how advocates can succeed by adopting new approaches grounded in precision, patience, and credibility. Session is FREE and open to everyone! Registration required: buff.ly/8LKSgD2
January 20, 2026 at 1:02 PM
Happening today at noon ET! FASEB's Ellen Kuo will share what advocacy strategies are effective, what’s changed, and how advocates can succeed by adopting new approaches grounded in precision, patience, and credibility. Session is FREE and open to everyone! Registration required: buff.ly/8LKSgD2